Associate Professor of Health Policy and Management, University of Pittsburgh Health Sciences
Jarlenski's work advances knowledge about how policies may affect pregnancy and reproductive health. Currently, she leads a multi-disciplinary research group with Elizabeth Krans to investigate how to improve health outcomes for persons with opioid use disorders in pregnancy. She is Principal Investigator of two research projects: 1) research using real-world data to understand access to and quality of OUD treatment and pregnancy outcomes (R01DA045675), and 2) an implementation-effectiveness trial of a provider-level intervention to improve OUD treatment in pregnancy and subsequent outcomes (R01DA049759). Jarlenski also conducts work under an inter-governmental agreement to provide research support for the Pennsylvania Medicaid program, where she currently co-leads (with Dara Mendez) a Robert Wood Johnson Foundation funded project to study interventions to advance racial equity in pregnancy and birth outcomes. She has authored or co-authored more than 70 peer-reviewed publications, and her work has been cited by state and national policy-makers. Jarlenski earned her Ph.D. from the Johns Hopkins Bloomberg School of Public Health, M.P.H. from the Yale School of Public Health, and B.A. from Otterbein College.
Oct 31, 2022 08:43 am UTC| Health
The U.S. Food and Drug Administration is set to review a drugmakers application for the first over-the-counter birth control pill in November 2022, with a decision expected in the first half of 2023. An approved...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight